NEW ORLEANS–(BUSINESS WIRE)–Visioneering Technologies, Inc. (ASX:VTI), produttrice del NaturalVue®Multifocal 1 Day Contact Lenses, ha presentato i dati intermedi dello studio clinico PROTECT al meeting annuale dell’American Academy of Optometry. I da…
Author: Business Wire
Resumen: VTI anuncia datos provisionales positivos a un año del ensayo clínico PROTECT en la reunión anual de la Academia Americana de Optometría
NEW ORLEANS–(BUSINESS WIRE)–Visioneering Technologies, Inc. (ASX:VTI), fabricante de las lentes de contacto NaturalVue® Multifocal 1 Day, presentó datos provisionales del ensayo clínico PROTECT en la reunión anual de la Academia Americana de Optometr…
Samenvatting: VTI kondigt positieve tussentijdse gegevens over één jaar aan van het klinische PROTECT-onderzoek op de jaarlijkse bijeenkomst van de American Academy of Optometry
NEW ORLEANS–(BUSINESS WIRE)–Visioneering Technologies, Inc. (ASX:VTI), producent van de NaturalVue® multifocale 1-dagcontactlenzen, presenteerde tussentijdse gegevens van de klinische PROTECT-studie op de jaarlijkse bijeenkomst van de American Academ…
VTI Announces Positive Interim 1-Year Data from the PROTECT Clinical Trial at American Academy of Optometry Annual Meeting
NEW ORLEANS–(BUSINESS WIRE)–VTI Unveils Interim 1-Year PROTECT RCT Data at AAOpt Annual Meeting; NaturalVue® Contact Lenses Proven Safe & Effective for Myopia Management
AscellaHealth President and CEO Dea Belazi Delivers Impactful Discussion at 2023 SIIA Annual Meeting: Specialty Pharmaceuticals and their Impact on Self-Insured Employers
BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth, a global healthcare and specialty pharmacy SP) solutions company, announces that CEO and President Belazi was invited to participate on a panel during the recent 2023 annual meeting of the Self Insurance Ins…
Half a Million Factory Workers in Low-Income Countries Have Vision Screened in Landmark Project Led by Alliance of US Businesses – a Milestone Announced Today, World Sight Day
NEW YORK–(BUSINESS WIRE)–On World Sight Day, an annual day of awareness to focus on vision impairment and eye health, the social enterprise VisionSpring has announced that it has screened the vision of half a million factory workers in a coalition to…
Tilak Healthcare Raises €10 Million to Continue Growing Its Leading Ophthalmological Telemedicine Offering
PARIS–(BUSINESS WIRE)–Tilak Healthcare, a pioneer and leading player in the field of ophthalmological digital health, has raised €10 million in a funding round led by Elaia and Cap Horn. They were joined by long-standing investors iBionext and SWEN C…
Aviceda Announces AVD-104, a Novel Glycomimetic Nanoparticle, Demonstrates Continued Clinical Safety in the Treatment of Geographic Atrophy Secondary to Macular Degeneration
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics, a privately held, late-stage clinical biotech company focused on developing next-generation immunomodulators by harnessing the power of glycobiology to alleviate chronic non-resolving inflammatio…
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
WATERTOWN, Mass.–(BUSINESS WIRE)–Dyno announces Scientific Symposium and presentation of three research abstracts at ESGCT 2023.
Lineage Announces Issuance of U.S. Patent Covering Proprietary Manufacturing and Differentiation Process for Retinal Pigmented Epithelial Cells
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces the launch of two new promotional programs for ophthalm…
Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release third…
EyeSouth Partners Unveils Two Ambulatory Surgery Centers For Its Affiliates In Orlando and Chicago Areas
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or “the company”) is pleased to unveil its two latest surgery centers, Heathrow Surgery Center, and the EyeSouth Surgery Center at Oak Lawn, representing its first official Ambulatory Surgical Cen…
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia
GENEVA–(BUSINESS WIRE)–Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia
Genentech’s Vabysmo Maintained Vision Improvements With Extended Treatment Intervals Up to Four Months for People With Retinal Vein Occlusion (RVO) in Phase III Trials
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive topline long-term results from the global Phase III BALATON and COMINO studies evaluating extended treatment int…
National Vision Releases 2022 Sustainability Report
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), America’s second largest optical retailer (by sales), released its 2022 Sustainability Report, “A World Worth Seeing,” reflecting continued progress against the environmental, …
North Dakota Parks First in Nation to Offer EnChroma Glasses for Color Blindness at All State Parks for Visitors
BISMARCK, N.D. & BERKELEY, Calif.–(BUSINESS WIRE)– #enchroma–North Dakota Parks and Recreation Department (NDPRD) today announced that it has become the first park system in the country to support “color accessibility” for color blind visitors at al…
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced one podium presentation and four poster presentations during the A…
Unlock the Potential of Patient Examination Devices: Your Path to Enhanced Diagnostic Precision – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Patient Examination Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033” report has been added to ResearchAndMarkets…
Aura Biosciences Strengthens and Expands Leadership Team with Key Appointments
BOSTON–(BUSINESS WIRE)–Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the appointments of Jill Hopk…